Skip to main content
Caplight Logo









T-Heart

T-Heart

Private
ParisHealthcare & Life Scienceshttps://theartvalve.com/

Company Overview

T-Heart is a medical device company developing a novel transcatheter prosthetic heart valve for the treatment of tricuspid regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

transcatheter tricuspid valve replacementTTVRstructural heart devicetricuspid regurgitationTRprosthetic heart valvemedtechheart valve replacementminimally invasive surgeryinterventional cardiologytranscatheter delivery systemmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

T-Heart Comparables

Compare T-Heart with similar companies based on industry and business-model similarity.

T-Heart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VDyne
93%
Trisol Medical
91%
Laplace Interventional
89%

T-Heart Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

T-Heart Investors

Notable investors and investment history

T-Heart investors
InvestorRounds
iBionextSeed, Series A

T-Heart Filings

Explore SEC and related filing metadata, where available.

T-Heart filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about T-Heart's valuation, stock price, and market status.

Is T-Heart a public or private company?

T-Heart is a private company.

What is the current stock price of T-Heart?

T-Heart is a private company with no public stock price. No recent secondary market data is available.

How much is T-Heart worth (valuation)?

Valuation information for T-Heart is not publicly available.

Can I buy T-Heart stock?

T-Heart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was T-Heart's last funding round?

Funding round information for T-Heart is not publicly available.

Who are the main investors in T-Heart?

Key investors in T-Heart include iBionext.

Will T-Heart IPO soon?

No public IPO plans have been announced for T-Heart.

How can I track T-Heart secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor T-Heart's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?